Fundación Teófilo Hernando (FTH)

Logo Fundación Teófilo Hernando (FTH)

Contact information

Fundación Teófilo Hernando (FTH)
Arturo García de Diego, CEO
Parque Científico de Madrid, UAM; c/ Faraday 7. Edificio Claid
(+34) 911 923 700
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biodrugs
      • Biomarkers
      • Stem cells
      • Cell cultures
      • In vitro diagnostics
      • Diagnostic imaging
      • Medical devices
      • Drug development
      • Drug discovery
      • Blood products
      • Screening
      • Cellular Therapy
      • Gene Therapy
      • Biomaterials and tissue therapy
      • Vaccines
      • Maintenance of cell cultures
    • Therapeutic areas
      • Analgesia & Pain
      • Dermatology
      • Musculoskeletal system
      • Cardiovascular diseases and circulatory system
      • Genetic and rare diseases
      • Infectious diseases
      • Inflammatory diseases
      • Gynaecology and obstetrics
      • Immunology
      • Ophtalmology and optometry
      • Oncology
      • Blood and lymphatic system
      • Digestive system and hepatology
      • Kidney and genitourinary system
      • Central nervous system
      • Respiratory and pulmonary system
      • Metabolic disorders / Endocrinology
  • D. Services
    • R&D services
      • CRO / CMO / SMO

The mission of the FTH is based on its contribution to the clinical development of new medicines. Leveraging the health and quality of life of the citizenship. Additionally, we are committed to contributing to the rigorous training of researchers, in order to facilitate their employment and professional advancement in the different professional frameworks of medicine discovery and development. And as a corollary of these two activities, the FTH supports numerous scientific, humanistic, educational and cultural actions.

Products and services

Kindly check our CRO Services in our website:

Areas of interest for future collaborations

Offer services with the highest quality and efficiency as CRO across the Iberian Peninsula and international pharmaceutical industry, international CROs which do not have HQs / office in Spain. Develop partnerships and win-win alliances with CROs, the pharmaceutical industry and Principal Investigators (PI) who are developing projects mainly in Europe, the United States, and Canada.